Literature DB >> 22903389

Pharmacological effects of cannabinoids on the reference and working memory functions in mice.

Avdesh Avdesh1, Yikai Hoe, Ralph N Martins, Mathew T Martin-Iverson.   

Abstract

RATIONALE: Evidence indicates cannabinoid receptor agonists impair performance in procedures to assess memory that may also be confounded by motivational or motor effects, both of which occur with cannabinoids. Thus, convergence of evidence from a variety of procedures that differ in motivation, attention, arousal and response requirements, but share a common reliance on memory, is required. There are no current reports on cannabinoid effects on mice tested in the radial arm maze.
OBJECTIVES: The objective was to determine the effects of the cannabinoid agonist CP 55940 and the dependence of any such effects on the CB1 receptor using the CB1 receptor antagonist SR 141716A on two strains of mice in the eight-arm radial maze procedure.
METHODS: Male C57BL/6J (N = 36) and C3H/HEJ (N = 12) mice were trained to a criterion and then were treated (IP) with vehicle + vehicle, SR 141716A + vehicle, vehicle + CP 55940 and SR 141716A + CP 55940 in a fully balanced mixed design prior to further tests in the maze. Reference (long-term) and working (short-term) memory were assessed.
RESULTS: CP 55940 impaired performance of the reference memory task in the C57BL/6J strain but not the C3H/HEJ strain; SR 141716A reversed the effect of CP 55940 on these measures. CP 55940 also increased working memory errors in the C57BL/6J mice only, which was not affected by SR 141716A.
CONCLUSION: The present study provides evidence for a strain-specific effect of a dose of CP 55940 on reference memory. While the cannabinoid agonist also impaired working memory in one strain, this effect was apparently not mediated by CB1 receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903389     DOI: 10.1007/s00213-012-2834-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  Effects of chronic marijuana use on human cognition.

Authors:  R I Block; M M Ghoneim
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Authors:  P J Little; D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

Review 6.  Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Alex Perchuk; Paul A Meozzi; Lester Myers; Zoila Mora; Patricia Tagliaferro; Eileen Gardner; Alicia Brusco; Babatunde E Akinshola; Qing-Rong Liu; Bruce Hope; Shinya Iwasaki; Tadao Arinami; Lindsey Teasenfitz; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

7.  Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.

Authors:  K E Scholes; M T Martin-Iverson
Journal:  Psychol Med       Date:  2009-12-17       Impact factor: 7.723

8.  Cannabinoids modulate hippocampal memory and plasticity.

Authors:  Hila Abush; Irit Akirav
Journal:  Hippocampus       Date:  2010-10       Impact factor: 3.899

9.  Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.

Authors:  Eva M Romero; Beatriz Fernández; Onintza Sagredo; Nuria Gomez; Leyre Urigüen; Carmen Guaza; Rosario De Miguel; Jose Antonio Ramos; M Paz Viveros
Journal:  Brain Res Dev Brain Res       Date:  2002-06-30

10.  Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

Authors:  R S Mansbach; C C Rovetti; E N Winston; J A Lowe
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

View more
  3 in total

1.  CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-02       Impact factor: 3.899

2.  Cholecystokinin-Expressing Interneurons of the Medial Prefrontal Cortex Mediate Working Memory Retrieval.

Authors:  Robin Nguyen; Sridevi Venkatesan; Mary Binko; Jee Yoon Bang; Janine D Cajanding; Chloe Briggs; Derya Sargin; Itaru Imayoshi; Evelyn K Lambe; Jun Chul Kim
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

3.  Postnatal MK-801 treatment of female rats impairs acquisition of working memory, but not reference memory in an eight-arm radial maze; no beneficial effects of enriched environment.

Authors:  Masoumeh Nozari; Farshad Alizadeh Mansouri; Mohammad Shabani; Hojat Nozari; Nafiseh Atapour
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.